Worldwide Healthcare Trust PLC Informations sur les dividendes
Worldwide Healthcare Trust PLC a un dividende annuel de 0.0284 par action, avec un rendement de 0.00%. Le dividende est payé semestriellement et la dernière date d'ex-dividende était le Nov 27, 2025.
Rendement en dividend
Dividende annuel
Date ex-dividende
0.00%
$0.0284
Nov 27, 2025
Fréquence des paiements
Taux de distribution
Semestriellement
0.00%
Historique des dividendes
Date ex-dividende
Montant en espèces
Date de registre
Date de paiement
Nov 27, 2025
$0.007
Nov 28, 2025
Jan 9, 2026
Jun 12, 2025
$0.017
Jun 13, 2025
Jul 23, 2025
Nov 28, 2024
$0.007
Nov 29, 2024
Jan 9, 2025
Jun 13, 2024
$0.021
Jun 14, 2024
Jul 24, 2024
Nov 23, 2023
$0.007
Nov 24, 2023
Jan 11, 2024
Jun 8, 2023
$0.024
Jun 9, 2023
Jul 26, 2023
Graphiques des dividendes
WWHZF Dividendes
WWHZF Croissance des dividendes (variation annuelle)
Follow-Up Questions
Quel est le dividende actuel payé par Worldwide Healthcare Trust PLC et son dividende annuel ?
Quel est le ratio de distribution de dividendes de Worldwide Healthcare Trust PLC ?
Quelle est la date ex-dividende pour WWHZF ?
À quelle fréquence Worldwide Healthcare Trust PLC verse-t-elle des dividendes ?
Statistiques clés
Clôture préc.
--
Prix d'ouverture
--
Plage de la journée
-
Plage de 52 semaines
-
Volume
--
Volume moyen
--
BPA (TTM)
--
Rendement en dividend
--
Capitalisation boursière
--
Qu’est-ce que WORLDWIDE HEALTHCARE TRUST ?
Worldwide Healthcare Trust PLC is a GB-based company operating in industry. Worldwide Healthcare Trust PLC is a specialist investment trust. The company invests in the global healthcare sector with the objective of achieving a high level of capital growth. The company invests worldwide in a diversified portfolio of shares in pharmaceutical and biotechnology companies and related securities in the healthcare sector. The company will not invest more than 15% of the portfolio in any one individual stock at the time of acquisition. The company invests over 50% of the portfolio in larger companies, and 20% of the portfolio in smaller companies. The company may invest 5% of the portfolio, at the time of acquisition, in debt instruments, convertibles and royalty bonds issued by pharmaceutical and biotechnology companies. The company may invest 40% of the portfolio in companies in the healthcare equipment and supplies sector and 30% of the portfolio in companies in the healthcare providers and services sector. Its alternative investment fund manager is Frostrow Capital LLP. OrbiMed Capital LLC is its portfolio manager.